help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, X.-G.
Right arrow Articles by Cheng, S.-y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, X.-G.
Right arrow Articles by Cheng, S.-y.
Endocrinology Vol. 138, No. 4 1456-1463
Copyright © 1997 by The Endocrine Society


ARTICLES

Differential Sensitivity of Thyroid Hormone Receptor Isoform Homodimers and Mutant Heterodimers to Hormone-Induced Dissociation from Deoxyribonucleic Acid: Its Role in Dominant Negative Action

Xu-Guang Zhu, Peter McPhie and Sheue-yann Cheng

Laboratory of Molecular Biology (X.-G.Z., S.-y.C.), Division of Basic Sciences, National Cancer Institute, and Laboratory of Biochemical Pharmacology (P.M.), National Institute of Diabetes, Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892-4255

Address all correspondence and requests for reprints to: Dr. Sheue-yann Cheng, Building 37, Room 2D24, 37 Convent Drive MSC 4255, Bethesda, Maryland 20892-4255. E-mail: sycheng{at}helix.nih.gov

General resistance to thyroid hormone is an inheritable disease with resistance of peripheral tissues to elevated levels of thyroid hormone. Genetic studies have shown that it is due to interference in the functions of wild-type thyroid hormone nuclear receptors (wTRs) via the dominant negative effect of mutant TRs (mTRs). The present study compared the heterodimerization of the two TR isoforms, TRß1 and TR{alpha}1, with mutant TRs to understand if mTRs had isoform-dependent dominant negative action. Using electrophoresis gel mobility shift assay, we have demonstrated that mutant PV, S, ED, and OK form heterodimers with wTR{alpha}1 and {Delta}TRß1 (in which the A/B domain of wTRß1 has been deleted), on the F2-thyroid hormone response element (TRE). In the presence of T3, both homo- and heterodimer complexes are dissociated in a T3 concentration dependent manner. The ED50 for {Delta}TRß1 homodimers was 3-fold higher than that of wTR{alpha}1 homodimers. ED50s for {Delta}TRß1/mTR heterodimers were 10- to 40-fold higher than the corresponding wTR{alpha}1/mTR heterodimers. Mutant ED and OK homodimers were only partially dissociated at the highest T3 concentrations used (100 nM), whereas no dissociation could be detected for PV and S homodimers, indicating differential sensitivity of the F2-bound TR dimers to the T3-induced dissociation. We presented a model that indicates the dissociation of any particular TR dimer from F2 is determined by competition of T3 for both of its constituent TRs. By transfection assays, we showed that the potency of the dominant negative action of PV on TR{alpha}1 and TRß1 inversely correlated with the sensitivity of the appropriate mTR/wTR heterodimer to T3-induced dissociation from F2. The differential dominant negative action of mutants on the two TR isoforms could play an important role in the heterogeneity of tissue-specific manifestations in patients with resistance to thyroid hormone.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. M. Zavacki, H. Ying, M. A. Christoffolete, G. Aerts, E. So, J. W. Harney, S.-y. Cheng, P. R. Larsen, and A. C. Bianco
Type 1 Iodothyronine Deiodinase Is a Sensitive Marker of Peripheral Thyroid Status in the Mouse
Endocrinology, March 1, 2005; 146(3): 1568 - 1575.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Ying, H. Suzuki, L. Zhao, M. C. Willingham, P. Meltzer, and S.-Y. Cheng
Mutant Thyroid Hormone Receptor {beta} Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor {gamma} during Thyroid Carcinogenesis
Cancer Res., September 1, 2003; 63(17): 5274 - 5280.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. Suzuki, X.-Y. Zhang, D. Forrest, M. C. Willingham, and S.-Y. Cheng
Marked Potentiation of the Dominant Negative Action of a Mutant Thyroid Hormone Receptor {beta} in Mice by the Ablation of One Wild-Type {beta} Allele
Mol. Endocrinol., May 1, 2003; 17(5): 895 - 907.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
X.-Y. Zhang, M. Kaneshige, Y. Kamiya, K. Kaneshige, P. McPhie, and S.-Y. Cheng
Differential Expression of Thyroid Hormone Receptor Isoforms Dictates the Dominant Negative Activity of Mutant {beta} Receptor
Mol. Endocrinol., September 1, 2002; 16(9): 2077 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-m. Lin, L. Zhao, and S.-y. Cheng
Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors
J. Biol. Chem., August 2, 2002; 277(32): 28733 - 28741.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society